RT Journal Article SR Electronic T1 Prognostic significance of BMI after PCI treatment in ST-elevation myocardial infarction A cohort study from the Swedish Coronary Angiography and Angioplasty Registry JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.01.12.21249477 DO 10.1101/2021.01.12.21249477 A1 Shabbar Jamaly A1 Björn Redfors A1 Elmir Omerovic A1 Lena Carlsson A1 Kristjan Karason YR 2021 UL http://medrxiv.org/content/early/2021/01/20/2021.01.12.21249477.abstract AB Background Obesity along with clustering of cardiovascular risk factors is a promoter for coronary artery disease. On the other hand, a high BMI appears to exert a protective effect with respect to outcomes after a coronary artery event, termed the obesity paradox.Methods The Swedish Coronary and Angiography and Angioplasty registry (SCAAR) collects information on all patients who undergo percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) in Sweden along with demographic- and procedure-related data. We studied the predictability of four categories of BMI for 1-year all-cause mortality in people with STEMI undergoing PCI.Results Among 25,384 patients, mean (SD) age 67.7 (12.1) years and 71.1% male, who underwent PCI for STEMI a total of 5,529 (21.8%) died within one year. Using normal-weight (BMI 18.5-24.9 kg/m2) as a reference, subjects with obesity (BMI ≥30 kg/m2) had a low 1-year all-cause mortality risk in unadjusted analysis, HR 0.59 (95% CI 0.53– 0.67). However, after adjustment for age, sex and other covariates the difference became non-significant, HR 0.88 (95% CI: 0.75-1.02). Patients with overweight (BMI 25.0-29.9 kg/m2) had the lowest 1-year mortality risk in analysis adjusted for age, sex and other covariates, HR 0.87 (95% CI 0.79-0.95), whereas those with underweight (BMI <18.5 kg/m2) had the highest mortality in both unadjusted HR 2.22 (95% CI 1.69–2.92) and adjusted analysis, HR 1.72 (95% CI: 1.31-2.26).Conclusion The protective effect of obesity with respect to 1-year mortality after coronary intervention became non-significant after adjusting for age, sex and relevant co-variates. Instead, overweight people displayed the lowest risk and underweight individuals the highest risk for adjusted all-cause mortalityCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02311231Funding StatementResearch reported in this publication was funded by the Swedish federal government under the ALF agreement (ALFGBG-932636, ALFGBG-775351, ALFGBG-633141)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by the regional ethical committee in Gothenburg Nr 288-14All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOn request the data is available for examination